Class information for:
Level 1: POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER//PTLD//POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
2532 2145 30.3 83%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
668 12550 NASOPHARYNGEAL CARCINOMA//EPSTEIN BARR VIRUS//EBV

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER Author keyword 250 71% 10% 204
2 PTLD Author keyword 201 73% 7% 152
3 POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE Author keyword 98 71% 4% 79
4 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS Author keyword 75 80% 2% 47
5 POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER Author keyword 52 87% 1% 26
6 POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE Author keyword 48 77% 2% 33
7 POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS Author keyword 47 81% 1% 29
8 POST TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER Author keyword 22 63% 1% 22
9 POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE Author keyword 21 90% 0% 9
10 LYMPHOPROLIFERATIVE DISORDER Author keyword 16 24% 3% 58

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 250 71% 10% 204 Search POST+TRANSPLANT+LYMPHOPROLIFERATIVE+DISORDER Search POST+TRANSPLANT+LYMPHOPROLIFERATIVE+DISORDER
2 PTLD 201 73% 7% 152 Search PTLD Search PTLD
3 POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE 98 71% 4% 79 Search POST+TRANSPLANT+LYMPHOPROLIFERATIVE+DISEASE Search POST+TRANSPLANT+LYMPHOPROLIFERATIVE+DISEASE
4 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS 75 80% 2% 47 Search POST+TRANSPLANT+LYMPHOPROLIFERATIVE+DISORDERS Search POST+TRANSPLANT+LYMPHOPROLIFERATIVE+DISORDERS
5 POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER 52 87% 1% 26 Search POSTTRANSPLANTATION+LYMPHOPROLIFERATIVE+DISORDER Search POSTTRANSPLANTATION+LYMPHOPROLIFERATIVE+DISORDER
6 POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE 48 77% 2% 33 Search POSTTRANSPLANT+LYMPHOPROLIFERATIVE+DISEASE Search POSTTRANSPLANT+LYMPHOPROLIFERATIVE+DISEASE
7 POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS 47 81% 1% 29 Search POSTTRANSPLANT+LYMPHOPROLIFERATIVE+DISORDERS Search POSTTRANSPLANT+LYMPHOPROLIFERATIVE+DISORDERS
8 POST TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER 22 63% 1% 22 Search POST+TRANSPLANTATION+LYMPHOPROLIFERATIVE+DISORDER Search POST+TRANSPLANTATION+LYMPHOPROLIFERATIVE+DISORDER
9 POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE 21 90% 0% 9 Search POSTTRANSPLANTATION+LYMPHOPROLIFERATIVE+DISEASE Search POSTTRANSPLANTATION+LYMPHOPROLIFERATIVE+DISEASE
10 LYMPHOPROLIFERATIVE DISORDER 16 24% 3% 58 Search LYMPHOPROLIFERATIVE+DISORDER Search LYMPHOPROLIFERATIVE+DISORDER

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PTLD 149 88% 3% 71
2 POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE 81 43% 7% 144
3 POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS 47 36% 5% 106
4 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 42 34% 5% 103
5 EBV REACTIVATION 40 71% 1% 32
6 DISTINCT ENTITY 34 44% 3% 58
7 SOLID ORGAN TRANSPLANTATION 32 15% 9% 202
8 UNFRACTIONATED WHOLE BLOOD 27 74% 1% 20
9 MONOCLONAL ANTIBODY RITUXIMAB 21 26% 3% 71
10 VIRAL LOAD CARRIAGE 20 100% 0% 9

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT 2014 7 38 68%
How I treat EBV lymphoproliferation 2009 95 60 78%
Post-transplant lymphoproliferative disorders 2005 213 73 74%
T-cell therapy in the treatment of post-transplant lymphoproliferative disease 2012 49 74 58%
Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative Disorder 2010 64 185 68%
Post-transplant lymphoproliferative disorder: a review 2003 113 66 88%
Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation 2005 148 79 81%
Lymphoproliferative Disorders After Solid Organ Transplantation-Classification, Incidence, Risk Factors, Early Detection and Treatment Options 2011 29 94 79%
Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases 2009 62 86 78%
Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients 2014 3 80 88%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CLIN IMMUNOHAEMATOL 2 26% 0.3% 6
2 INTERNIST 1 38% 0.1% 3
3 HOSP VOGHERA 1 100% 0.1% 2
4 HUMAN PATHOLANAT PATHOL SECT 1 100% 0.1% 2
5 VIROL MICROBIOL MED BIOTECHNOL 1 100% 0.1% 2
6 EBV BIOL 1 33% 0.1% 3
7 TRANSPLANT IMMUNOL PEDIAT HEMATOL ONCOL 1 40% 0.1% 2
8 W SCOTLAND CANC 1 40% 0.1% 2
9 NEPHROL INTENS CARE 1 11% 0.4% 9
10 SICKKIDS TRANSPLANT 1 18% 0.2% 5

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000199032 AUSTRALIAN VACCINE DEV TUMOUR IMMUNOL//EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 1//JOINT ONCOL PROGRAM
2 0.0000141870 DE NOVO MALIGNANCIES//DONOR MALIGNANCY//TUMOR TRANSMISSION
3 0.0000110127 INFECTIOUS MONONUCLEOSIS//MONONUCLEOSIS//ACUTE EBV INFECTION
4 0.0000099612 CHROMOSOME 5 ABNORMALITY//PHARM NTHC NARILIS//UNIDAD HEMATOL CLIN
5 0.0000075362 PLASMABLASTIC LYMPHOMA//PLASMABLASTIC//HUMAN IMMUNODEFICIENCY VIRUS NEGATIVE
6 0.0000074814 LMP1//LATENT MEMBRANE PROTEIN 1//EBV
7 0.0000070529 CMV SPECIFIC T CELLS//ONCOHEMATOL GRP//CYTOMEGALOVIRUS SPECIFIC T CELLS
8 0.0000053678 AIDS RELATED LYMPHOMA//NON AIDS DEFINING CANCER//NON AIDS DEFINING CANCERS
9 0.0000053162 GENITAL GVHD//CARDIAC LATE EFFECTS//HCT HEMATOPOIETIC CELL TRANSPLANTATION
10 0.0000049770 XLP//2B4//X LINKED LYMPHOPROLIFERATIVE DISEASE